167 related articles for article (PubMed ID: 33037638)
1. Dominant immune response to HLA-B57/B58 molecules after platelet transfusion.
Coombs J; Ben Hassen L; Leclerc M; Tamagne M; Pannetier L; Khelfa M; Delorme A; Bocquet T; Maury S; Pirenne F; Ansart-Pirenne H; Vingert B
Transfusion; 2020 Dec; 60(12):2807-2814. PubMed ID: 33037638
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
Panch SR; Guo L; Vassallo R
Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
[TBL] [Abstract][Full Text] [Related]
3. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
Saris A; Kerkhoffs JL; Norris PJ; van Ham SM; Ten Brinke A; Brand A; van der Meer PF; Zwaginga JJ
Transfusion; 2019 Feb; 59(2):470-481. PubMed ID: 30499599
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
5. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
6. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
[TBL] [Abstract][Full Text] [Related]
7. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
8. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
9. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
10. Divergent CD4
Khelfa M; Leclerc M; Kerbrat S; Boudjemai YNS; Benchouaia M; Neyrinck-Leglantier D; Cagnet L; Berradhia L; Tamagne M; Croisille L; Pirenne F; Maury S; Vingert B
Front Immunol; 2023; 14():1165973. PubMed ID: 37701444
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
[TBL] [Abstract][Full Text] [Related]
12. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
Saris A; Pavenski K
Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
[TBL] [Abstract][Full Text] [Related]
13. HLA molecule expression on the surface of cells and microparticles in platelet concentrates.
Pannetier L; Tamagne M; Bocquet T; Pirenne F; Ansart-Pirenne H; Vingert B
Transfusion; 2021 Apr; 61(4):1023-1028. PubMed ID: 33241556
[TBL] [Abstract][Full Text] [Related]
14. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
Couvidou A; Rojas-Jiménez G; Dupuis A; Maître B
Front Immunol; 2023; 14():1125367. PubMed ID: 36845153
[TBL] [Abstract][Full Text] [Related]
15. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
[TBL] [Abstract][Full Text] [Related]
16. Identification of platelet refractoriness in oncohematologic patients.
Ferreira AA; Zulli R; Soares S; Castro Vd; Moraes-Souza H
Clinics (Sao Paulo); 2011; 66(1):35-40. PubMed ID: 21437433
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
Gilson CR; Zimring JC
Transfusion; 2012 Apr; 52(4):849-59. PubMed ID: 21981241
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions.
Abraham AS; Chacko MP; Fouzia NA; Srivastava A; Daniel D
Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307
[TBL] [Abstract][Full Text] [Related]
19. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
Front Immunol; 2018; 9():1251. PubMed ID: 29951051
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
